3CC | Third Culture Capital

Binkey is a financial technology company that helps merchants to accepts FSA and HSA as a form of payment.

Ciba Health is a personalized digital therapeutics and virtual care platform that focuses on treating and reversing chronic conditions through a precision health approach. The company empowers patients by promoting self-care and offering a patient-centered, root-cause methodology. Ciba Health emphasizes a value-based care delivery model that integrates full-spectrum care, providing convenient access to multidisciplinary teams. By leveraging advanced technology, it implements individualized treatment plans that address the physical, mental, and lifestyle needs of patients, fostering improvements in overall well-being.

Ciba Health is a personalized digital therapeutics and virtual care platform that focuses on treating and reversing chronic conditions through a precision health approach. The company empowers patients by promoting self-care and offering a patient-centered, root-cause methodology. Ciba Health emphasizes a value-based care delivery model that integrates full-spectrum care, providing convenient access to multidisciplinary teams. By leveraging advanced technology, it implements individualized treatment plans that address the physical, mental, and lifestyle needs of patients, fostering improvements in overall well-being.

Zuri Fertility is a developer of a fertility technology application designed to assist couples in managing their fertility journey. The platform provides a range of resources, including a questionnaire that evaluates medical and fertility history, a home testing tracker, and a medical concierge service. Additionally, Zuri Fertility offers communication support to enhance the user experience. By simplifying the complexities of the fertility treatment process, the application aims to focus users on their primary goal: starting a family. This patient-centered approach not only saves time and costs but also creates a more manageable and supportive environment for individuals navigating their fertility options.

Voiceitt Ltd., established in 2012 and headquartered in Ramat Gan, Israel, specializes in developing mobile applications that empower individuals with speech impairments or non-standard speech patterns to communicate effectively. The company's core product is an automatic speech recognition platform that translates distorted pronunciation into intelligible speech, providing independence and improved quality of life for users with speech and motor disabilities, as well as serving as a useful tool for their caregivers.

SimpliFed is a telehealth company founded in 2020 that focuses on providing virtual breastfeeding support to new and expectant parents. It addresses the challenges faced by these individuals, such as sleep deprivation and concerns about infant nutrition. SimpliFed offers a maternal care platform that delivers virtual-first care throughout the peri and postnatal periods. The company specializes in lactation and baby feeding support, as well as monitoring high-risk conditions like hypertension and gestational diabetes. By engaging with patients early, SimpliFed’s care navigators facilitate a comprehensive maternal care experience, allowing parents to receive timely answers to their questions about infant feeding through secure online and video connections.

KeyWise AI is a technology company founded in 2019 by Raeanne C. Moore, specializing in the development of artificial intelligence software designed to objectively and precisely track brain function. The company's innovative software eliminates guesswork in mental health assessments by producing individualized metrics that facilitate precision treatments and personalized interventions. This technology enables users to remotely monitor their mental health, improving early detection of brain disorders and supporting effective management strategies. KeyWise AI aims to enhance the overall understanding and treatment of mental health through advanced data-driven insights.

AcousticaBio is a biotechnology company focused on reformulating intravenous medications for subcutaneous administration. It has developed a fluid processing technology that enables the creation of complex microparticles necessary for effective subcutaneous formulations. By converting intravenously delivered biologic products into highly concentrated, small-volume injections, AcousticaBio aims to enhance patient experiences by allowing for self-administration of life-saving medications. This innovation significantly reduces the pain and discomfort associated with traditional delivery methods and minimizes the need for lengthy hospital visits, improving accessibility and convenience for patients.

Aviwell is a company focused on enhancing animal health and growth through the development of natural and sustainable solutions. Utilizing a microbiota-based platform powered by artificial intelligence and machine learning, Aviwell operates at the intersection of digital and life sciences. The company aims to provide insights that improve animal health and performance while addressing the agri-food industry's challenges in sustainably feeding a growing global population. By prioritizing health and sustainability, Aviwell seeks to offer effective solutions at a reduced cost, ultimately contributing to better nourishment for the planet.

SimpliFed is a telehealth company founded in 2020 that focuses on providing virtual breastfeeding support to new and expectant parents. It addresses the challenges faced by these individuals, such as sleep deprivation and concerns about infant nutrition. SimpliFed offers a maternal care platform that delivers virtual-first care throughout the peri and postnatal periods. The company specializes in lactation and baby feeding support, as well as monitoring high-risk conditions like hypertension and gestational diabetes. By engaging with patients early, SimpliFed’s care navigators facilitate a comprehensive maternal care experience, allowing parents to receive timely answers to their questions about infant feeding through secure online and video connections.

Intus Care, Inc. is a healthcare analytics company that specializes in connecting home care providers with patients through its innovative platform. Founded in 2018 and based in North Providence, Rhode Island, the company leverages machine learning and electronic health records to enhance the efficiency of care delivery. Its application enables provider organizations to conduct electronic visit verification and predict hospital readmissions and utilization risks. Additionally, Intus Care's platform facilitates automatic patient risk grouping and tracking, identifies patients at high risk for hospitalization, and sends alerts regarding changes in patient health status to care coordination teams. By synthesizing financial, clinical, and administrative data, Intus Care helps healthcare organizations, including PACE programs and long-term care facilities, visualize trends and implement data-driven interventions aimed at improving patient care and reducing hospitalizations for vulnerable populations.

Docosan is a tech startup focused on enhancing access to quality healthcare in Vietnam. Its digital marketplace allows patients to compare healthcare providers across various specialties, schedule appointments online at any time, communicate with primary care assistants, and manage their health data without cost. The platform benefits providers by offering tools to manage patients and expand their client base. Docosan's services are designed to improve access to primary healthcare, coordinate care effectively, and generate valuable public health data. The platform adheres to HIPAA compliance standards and employs internationally-recognized protocols such as HL7 FHIR and DICOM to ensure the portability of health records across different electronic health record systems. Docosan is committed to improving healthcare outcomes for the Vietnamese population.

Pragma Bio is a biotechnology company that focuses on developing microbiome-based therapeutics for cancer and autoimmune diseases. Founded in 2018 in Millbrae, California, by Peter McCaffrey, Kovi Bessoff, Ayin Vala, and Kareem Barghouti, the company utilizes proprietary genomic sequencing, artificial intelligence, and synthetic biology techniques to discover biomarkers and therapeutics for complex immunologic disorders. Pragma Bio's platform aggregates both public and private data to create a comprehensive microbiome database, enhancing the ability to identify connections between diverse biological data. This approach not only aids in the discovery of novel biomarkers for patient risk stratification and clinical outcome prediction but also enables the identification of small molecules derived from human-associated bacteria. By leveraging real-world data and advanced analytical processes, Pragma Bio aims to streamline drug discovery and deliver innovative medicines more efficiently and cost-effectively, particularly in relation to the gut-immune axis.